Auxilium Inks $657M Deal For Erectile Dysfunction Drug Co.

Law360, New York (April 29, 2013, 1:24 PM EDT) -- Pennsylvania-based hormone and male reproductive drug maker Auxilium Pharmaceuticals Inc. has completed its acquisition of private equity-backed Illinois erectile dysfunction drug company Actient Holdings LLC in a deal that could be worth up to $657.3 million, the companies announced Monday.

Auxilium said it made an upfront cash payment of $585 million to Actient stakeholders. The deal also additional Auxilium stock options worth a combined $22.3 million and contingent payments of up to $50 million based on future revenue targets.

The Illinois firm was founded in March...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.